Renata Limited
Ananta Saha has a strong background in international business, with experience in various managerial roles. Ananta began their career at Syntho Laboratories Limited in 2008 as a Product Executive in the Product Management Department, where they focused on developing marketing strategies and training the field force. In 2011, they joined Renata Limited as an Assistant Manager of International Business, where they coordinated operations in multiple countries and oversaw product marketing and regulatory support. Ananta then advanced to Deputy Manager, Senior Additional Manager, and International Business Manager, successfully developing business in Afghanistan, the Philippines, and multiple West African countries. Currently, Ananta Saha holds the position of Head of International Business Division at Renata Limited.
Ananta Saha completed a Master of Business Administration (MBA) in International Business from Dhaka University between 2015 and 2017. Prior to that, from 2007 to 2009, Ananta Saha pursued a degree in M.S. Pharm Tech in Pharmaceutical Sciences from the University of Asia Pacific. And before that, from 2003 to 2009, Ananta Saha obtained a Master of Science in Pharmaceutical Technology degree from The University of Asia Pacific with a specialization in Pharmacy.
This person is not in any teams
This person is not in any offices
Renata Limited
39 followers
Main Business: Manufacture and Marketing of Human Pharmaceuticals and Animal Therapeutics. We have two production sites. The Mirpur Site is 12 Acres and Rajendrapur Site is 17 Acres. History: The Company started its operations as Pfizer (Bangladesh) Limited in 1972. For the next two decades it continued as a highly successful subsidiary of Pfizer Corporation. However, by the late 1990s the focus of Pfizer had shifted from formulations to research. In accordance with this transformation, Pfizer divested its interests in many countries, including Bangladesh. Specifically, in 1993 Pfizer transferred the ownership of its Bangladesh operations to local shareholders, and the name of the company was changed to Renata Limited. In a gesture of corporate charity, Pfizer donated shares so that, along with a partial payment from the SAJIDA Foundation, 51% ownership of Renata Limited would be held by the Foundation. Today SAJIDA’s microfinance and micro-insurance programs support over 107,120 members and their families; thus far cumulative loan disbursement totals BDT 5,750 million. Currently, SAJIDA’s health program covers over 1 million beneficiaries by delivering services through two 70 bed hospitals, panel doctors in SAJIDA’s micro finance branches, and mobile health teams. To date, the SAJIDA Foundation holds the majority ownership in Renata Limited. To learn more please visit the foundation’s website: www.sajidafoundation.org